The Value of MRI before Prostate Biopsy cer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, pop- ulation-based randomized controlled trial. Eur Urol 2007;51: 659-64. 19. Oberaigner W, Horninger W, Klocker H, Schönitzer D, Stühlinger W, Bartsch G. Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing. Am J Epidemiol 2006 15;164:376-84. 20. Lemaitre L, Puech P, Poncelet E, Bouyé S, Leroy X, Biserte J, et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prosta- tectomy findings. Eur Radiol 2009;19:470-80. 21. Bouyé S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A. Transition zone and anterior stromal prostate cancers: zone of ori- gin and intraprostatic patterns of spread at histopathology. Prostate 2009;69:105-13. 22. Haffner J, Lemaitre L, Puech P, Haber GP, Leroy X, Jones JS, et al. Role of magnetic resonance imaging before initial biopsy: com- parison of magnetic resonance imaging targeted and systematic biopsy for significant prostate cancer detection. BJU Int 2011;22: doi: 10.1111/j.1464-410X.2011.10112.x 23. Rietbergen JB, Kruger AE, Hoedemaeker RF, Bangma CH, Kirkels MJ, Schröder FH. Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and patho- logical features of detected cancer. J Urol 1998;160:2121-5. 577 24. Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it? J Urol 1995;153:1496-8. 25. Keetch D, Catalona W, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994;151:1571-4. 26. Woodrum DL, Brawer MK, Partin AW, Catalona WJ, Southwick PC. Interpretation of free prostate specific antigen clinical re- search studies for the detection of prostate cancer. J Urol 1998;159:5-12. 27. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, et al. Use of the percentage of free prostate-specific anti- gen to enhance differentiation of prostate cancer from benign pro- static disease: a prospective multicenter clinical trial. JAMA 1998;279:1542-7. 28. Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F. Extended and saturation prostatic biopsy in the diag- nosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007;52:1309-22. 29. Shimizu T, Nishie A, Ro T, Tajima T, Yamaguchi A, Kono S, et al. Prostate cancer detection: the value of performing an MRI be- fore a biopsy. Acta Radiol 2009;50:1080-8. 30. Park SY, Kim JJ, Kim TH, Lim SH, Han DH, Park BK, et al. The role of endorectal magnetic resonance imaging in predicting ex- traprostatic extension and Seminal vesicle invasion in clinically localized prostate cancer. Korean J Urol 2010;51:308. Korean J Urol 2011;52:572-577